Oncorus Reviews

4.5

77% would recommend to a friend

(12 total reviews)

Mitchell H. Finer, Ph.D.

100% approve of CEO

62% positive business outlook

Reviews by job title

12 reviews
4.0
4 Jan 2025

Good place

Recommend
CEO approval
Business outlook

Pros

Collaboration between different departments for common goal

Cons

Leadership didn’t always agree with each other

5.0
29 Jul 2023
Recommend
CEO approval
Business outlook

Pros

Great company, innovative cancer immunotherapy platform

Cons

Suffered the fate of many biotech startups in a tough investment envirnoment

Viewing 1 - 3 of 12 Reviews

Glassdoor has 16 Oncorus reviews submitted anonymously by Oncorus employees. Read employee reviews and ratings on Glassdoor to decide if Oncorus is right for you.